Anti-interferon-gamma polyclonal antibody (Advanced Biotherapy)

N/A

Report date: 2022/09/01 11:16:36

Base Information

Drug NameAnti-interferon-gamma polyclonal antibody (Advanced Biotherapy)
Drug Alias NameAnti-IFN-γ polyclonal antibody - Advanced Biotherapyanti-IFN-γ (Advanced Biotherapy)A-IFN-gamma (Advanced Biotherapy)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterferon gamma inhibitors
TargetsInterferon gamma
Therapy Area/IndicationsMultiple SclerosisArthritis, RheumatoidHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdvanced Biotherapy Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Biotherapy Inc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisArthritis, RheumatoidHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A